{"id":1557746,"name":"Aclaris Therapeutics Inc","transferAgent":null,"allClaimedTransferAgents":[{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        ","asOfDate":{"value":"2022-04-21"},"docUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837022005681/tmb-20220602xdef14a.htm"},{"dtcMemberId":null,"name":"Broadridge Financial Solutions Inc.","asOfDate":{"value":"2020-12-17"},"docUrl":"https://www.nasdaqtrader.com/content/home/help/samplereports/Fundamental_Data_cusip121720.xlsx"}],"tickers":[{"ticker":"ACRS","exchange":"Nasdaq","description":"Common Stock","hasOnlinePurchase":null,"cusip":"00461U105"}],"holders":{"filingDate":{"value":"2022-02-24"},"totalHolders":61,"docUrls":["1557746/000155837022001838/acrs-20211231x10k.htm"]}}